PCK might see a long term reversal here - with regulatory...

PCK might see a long term reversal here - with regulatory approval for their infant product this will see a huge market opening. Dementia support was always going to be limited by government spending, but every parent is going to buy a product that is super easy to use and for $10/month can tell them their child is in pain.
If they can start taking this to market quickly it will be a massive revenue boost.

To me its a great buy signal and long term it is a no-brainer now that this hurdle has been passed.